TY - JOUR
T1 - Psychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapy
AU - Snipelisky, David
AU - Stulak, John M.
AU - Schettle, Sarah D.
AU - Sharma, Shashank
AU - Kushwaha, Sudhir S.
AU - Dunlay, Shannon M.
N1 - Funding Information:
Dr Dunlay''s research is supported by the NIH (K23 HL 116643). The authors have no potential conflicts of interest to disclose. All authors have approved the final article.
Publisher Copyright:
© 2015 Mosby, Inc.
PY - 2015
Y1 - 2015
N2 - Background Psychosocial factors impact survival in patients undergoing cardiac transplantation, but it is unclear whether they affect outcomes in patients undergoing left ventricular assist device (LVAD) implantation as destination therapy (DT). Methods Patients undergoing DT LVAD at the Mayo Clinic in Rochester, MN, from February 2007 to December 2013 were included. Psychosocial characteristics at the time of LVAD implantation were abstracted from the medical record. Andersen-Gill and Cox models were used to examine the association between psychosocial characteristics and all-cause readmission and death, respectively. Patients were censored at death or last follow-up through September 2014. Results Among 136 patients (mean age. 64 years; 17% female), most were married/living with a partner (82%), half (55%) had post-high school education, and a history of depression was common (32%). Although most patients were former tobacco users (60%) only a small proportion were current tobacco users (10%) and had a history of alcohol abuse (16%) or illegal drug use (7%). After a mean follow-up of 2.2 ± 1.8 years, 78% of patients had been readmitted (range, 0-14 per person) and 49% had died. There were no statistically significant differences in the risk of death according to psychosocial characteristics. However, current tobacco users had lower risk of readmission (adjusted HR, 0.57; 95% CI, 0.38-0.88), while illegal drug use (HR, 1.55; 95% CI, 1.01-2.35) and depression (HR, 1.77; 95% CI, 1.40-2.22) were associated with higher readmission risk. Conclusions Psychosocial characteristics are not significant predictors of death but are associated with readmission risk after DT LVAD.
AB - Background Psychosocial factors impact survival in patients undergoing cardiac transplantation, but it is unclear whether they affect outcomes in patients undergoing left ventricular assist device (LVAD) implantation as destination therapy (DT). Methods Patients undergoing DT LVAD at the Mayo Clinic in Rochester, MN, from February 2007 to December 2013 were included. Psychosocial characteristics at the time of LVAD implantation were abstracted from the medical record. Andersen-Gill and Cox models were used to examine the association between psychosocial characteristics and all-cause readmission and death, respectively. Patients were censored at death or last follow-up through September 2014. Results Among 136 patients (mean age. 64 years; 17% female), most were married/living with a partner (82%), half (55%) had post-high school education, and a history of depression was common (32%). Although most patients were former tobacco users (60%) only a small proportion were current tobacco users (10%) and had a history of alcohol abuse (16%) or illegal drug use (7%). After a mean follow-up of 2.2 ± 1.8 years, 78% of patients had been readmitted (range, 0-14 per person) and 49% had died. There were no statistically significant differences in the risk of death according to psychosocial characteristics. However, current tobacco users had lower risk of readmission (adjusted HR, 0.57; 95% CI, 0.38-0.88), while illegal drug use (HR, 1.55; 95% CI, 1.01-2.35) and depression (HR, 1.77; 95% CI, 1.40-2.22) were associated with higher readmission risk. Conclusions Psychosocial characteristics are not significant predictors of death but are associated with readmission risk after DT LVAD.
UR - http://www.scopus.com/inward/record.url?scp=84954288517&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84954288517&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2015.08.012
DO - 10.1016/j.ahj.2015.08.012
M3 - Article
C2 - 26542496
AN - SCOPUS:84954288517
SN - 0002-8703
VL - 170
SP - 887
EP - 894
JO - American Heart Journal
JF - American Heart Journal
IS - 5
ER -